Maximal model | Final model | |||
---|---|---|---|---|
HR (95% CI) | p value | HR (95% CI) | p value | |
Sex (ref. women) | 8.29 (1.93–35.49) | 0.004 | 10.12 (2.41–42.56) | 0.0016 |
SBP (mmHg) | 1.02 (0.99–1.04) | 0.157 | ||
DBP (mmHg) | 1.01 (0.97–1.05) | 0.552 | ||
eGFR, ml min−1 (1.73 m)−2 | 1.01 (0.99–1.03) | 0.331 | ||
uACR (reference < 3 mg/mmol)a | 0.840 | |||
3–30 | 1.36 (0.48–3.83) | |||
> 30 | 1.22 (0.38–3.92) | |||
Severe diabetic retinopathy (vs. no) | 3.50 (1.36–8.99) | 0.009 | 2.69 (1.31–5.57) | 0.0073 |
Macular edema (vs. no) | 0.92 (0.34–2.49) | 0.879 | ||
History of PAD (vs. no) | 5.38 (2.43–11.91) | < 0.001 | 4.37 (2.11–9.07) | < 0.001 |
TNFR1 (per 10 log pg/ml) | 1.11 (0.88–1.41) | 0.396 | ||
ANGPTL2 (per 10 log ng/ml) | 1.17 (0.95–1.46) | 0.135 | 1.25 (1.08–1.45) | 0.0025 |